Suppression of Mig-6 overcomes the acquired EGFR-TKI resistance of lung adenocarcinoma

被引：0
|
作者：
Da Hyun Kang
Sung Soo Jung
Min-Kyung Yeo
Da Hye Lee
Geon Yoo
Sang Yeon Cho
In-Jae Oh
Ju-Ock Kim
Hee Sun Park
Chaeuk Chung
Jeong Eun Lee
机构：
[1] College of Medicine,Division of Pulmonology, Department of Internal Medicine
[2] Chungnam National University,Department of Pathology, College of Medicine
[3] Chungnam National University,Department of Internal Medicine
[4] Korea Institute of Toxicology,undefined
[5] Chungnam National University School of Medicine,undefined
[6] Chonnam National University Medical School,undefined
来源：
BMC Cancer | / 20卷
关键词：
Mig-6; EGFR-TKI; Lung adenocarcinoma; Chemotherapy resistance;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Suppression of Mig-6 overcomes the acquired EGFR-TKI resistance of lung adenocarcinoma
    Kang, Da Hyun
    Jung, Sung Soo
    Yeo, Min-Kyung
    Lee, Da Hye
    Yoo, Geon
    Cho, Sang Yeon
    Oh, In-Jae
    Kim, Ju-Ock
    Park, Hee Sun
    Chung, Chaeuk
    Lee, Jeong Eun
    BMC CANCER, 2020, 20 (01)
  • [2] STE029 Overcomes EGFR-TKI Resistance in Human Lung Adenocarcinoma
    Huang, L.
    Zhou, Q.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (12) : S1072 - S1072
  • [3] Small cell transformation of lung adenocarcinoma in acquired resistance to EGFR-TKI
    So, Kwang Sup
    Choi, Yun Jung
    Kim, Sun Ye
    Choi, Chang-Min
    Lee, Jae Cheol
    Kim, Woo Sung
    Rho, Jin Kyung
    CANCER RESEARCH, 2013, 73 (08)
  • [4] Expression of selected gene for acquired drug resistance to EGFR-TKI in lung adenocarcinoma
    Uramoto, Hidetaka
    Shimokawa, Hidehiko
    Hanagiri, Takeshi
    Kuwano, Michihiko
    Ono, Mayumi
    LUNG CANCER, 2011, 73 (03) : 361 - 365
  • [5] Targeting the hippo effector YAP overcomes the de novo and acquired resistances to EGFR-TKI in lung adenocarcinoma
    Chung, Chaeuk
    Lee, Dahye
    Kim, Ju Ock
    Kim, Sun Young
    Lee, Jeong Eun
    Moon, Jea Young
    Park, Yeon Hee
    Jung, Sung Soo
    Park, Dong Il
    EUROPEAN RESPIRATORY JOURNAL, 2016, 48
  • [6] Hippo pathway effector YAP inhibition restores the sensitivity of EGFR-TKI in lung adenocarcinoma having primary or acquired EGFR-TKI resistance
    Lee, Jeong Eun
    Park, Hee Sun
    Lee, Dahye
    Yoo, Geon
    Kim, Tackhoon
    Jeon, Haeyon
    Yeo, Min-Kyung
    Lee, Choong-Sik
    Moon, Jae Young
    Jung, Sung Soo
    Kim, Ju Ock
    Kim, Sun Young
    Park, Dong Il
    Park, Yeon Hee
    Lee, Jae Cheol
    Oh, In-Jae
    Lim, Dae Sik
    Chung, Chaeuk
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2016, 474 (01) : 154 - 160
  • [7] TARGETING THE HIPPO EFFECTOR YAP OVERCOMES THE RESISTANCE TO EGFR-TKI OF BOTH EGFR MUTATED AND KRAS MUTATED LUNG ADENOCARCINOMA
    Chung, Chaeuk
    Park, Dongil
    Kim, Ju Ock
    Park, Hee Sun
    Lee, Jeong Eun
    Moon, Jae Young
    Lim, Daesik
    Lee, Jaechul
    RESPIROLOGY, 2015, 20 : 102 - 102
  • [8] Different first line EGFR-TKI regimen and the clearance of EGFR sensitive mutation in acquired EGFR-TKI resistant lung adenocarcinoma patients
    Zhuang, W.
    Xu, C.
    Wang, W.
    Song, Z.
    Zhu, Y.
    Chen, R.
    Guan, Y.
    Yi, X.
    Fang, M.
    Chen, G.
    Lv, T.
    Song, Y.
    ANNALS OF ONCOLOGY, 2017, 28
  • [9] Combining EGFR-TKI With SAHA Overcomes EGFR-TKI-Acquired Resistance by Reducing the Protective Autophagy in Non-Small Cell Lung Cancer
    Cao, Peijun
    Li, Yongwen
    Shi, Ruifeng
    Yuan, Yin
    Gong, Hao
    Zhu, Guangsheng
    Zhang, Zihe
    Chen, Chen
    Zhang, Hongbing
    Liu, Minghui
    Pan, Zhenhua
    Liu, Hongyu
    Chen, Jun
    FRONTIERS IN CHEMISTRY, 2022, 10
  • [10] EXPRESSION OF NOTCH-1 IN EGFR-TKI ACQUIRED RESISTANT LUNG ADENOCARCINOMA
    Xie, M.
    He, C. -S.
    Hou, J. -H.
    ANNALS OF ONCOLOGY, 2013, 24
12345